Recall
FDAHealthApril 21, 2026

ARROW INTERNATIONAL, LLC — Description/REF: ACCESS TRAY/ASK-04001-MC3

⚠️ Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
April 21, 2026

US Nationwide distribution including in the states of VA, NY, UT, SC, LA, MN, PA, AZ, CA, MI, OH, FL, CT, KS, IL, TX, WI, GA, NC, MD, OR, AK, NH, IA, ND, OK, NM, AL, MA, KY, WA, AR, CO, IN, ME, TN, WY, NJ, SD, MS, MO, MT, DE, ID, NE, WV, RI, VT, NV, HI, DC, PR.

What's affected?

Product
Description/REF: ACCESS TRAY/ASK-04001-MC3
Lot code
(Batch):

Additional details

REF(Material)/UDI-DI/Lot(Batch): ASK-04001-MC3/

What should I do?

Recommended action

Class I recall. Voluntary: Firm initiated Quantity affected: 8,265.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.